Mantle Cell Lymphoma

Test Your Knowledge

Quiz: What Monotherapy Shows Safety in R/R MCL?

11/11/2021

Which of the following monotherapies showed rapid and durable responses, an acceptable safety profile, and was generally well tolerated in BTK inhibitor-naïve patients with R/R MCL?

Which of the following...

11/11/2021

Oncology

News

Parsaclisib Monotherapy Well Tolerated in Patients With R/R MCL

11/11/2021

Parsaclisib monotherapy showed rapid and durable response, an acceptable safety profile, and was generally well tolerated in BTK inhibitor-naïve patients with R/R MCL; these data were presented at the 2021 ASH Annual Meeting.

Parsaclisib monotherapy showed...

11/11/2021

Oncology

Videos

Michael Wang, MD, Talks LOXO-305 for MCL, WM

12/07/2020

In this video, Dr Wang discusses the use of LOXO-305, a highly selective BTK inhibitor, in patients with pretreated MCL, WM, and other NHLs.

In this video, Dr Wang discusses...

12/07/2020

Oncology

News

MRD Testing to Identify High-Risk MCL Cases That Could Benefit From Alternate Therapies

12/08/2019

Study findings being presented at ASH 2019 posit that interim MRD testing at cycle 3 can help identify high-risk patients with MCL who may benefit from alternative therapies.

Study findings being presented...

12/08/2019

Oncology